Transcripts

Ani Pharmaceuticals (ANIP) earnings call transcripts

Earnings call transcripts for Ani Pharmaceuticals Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed execution as intact despite a modest Cortrofen guidance reduction, with existing specialties strong and gout expansion accelerating into fourth quarter.

    Aug 07, 2026Confident0.78